Skip to main content
Zealand Pharma A/S (CPH: ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
697.00
-13.50 (-1.90%)
Nov 21, 2024, 4:59 PM CET

Zealand Pharma Revenue

Zealand Pharma had revenue of 4.42M DKK in the quarter ending September 30, 2024, a decrease of -98.51%. This brings the company's revenue in the last twelve months to 76.87M, down -77.62% year-over-year. In the year 2023, Zealand Pharma had annual revenue of 342.79M with 229.65% growth.

Revenue (ttm)
76.87M
Revenue Growth
-77.62%
P/S Ratio
n/a
Revenue / Employee
257.95K
Employees
253
Market Cap
49.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020192.00M150.67M364.52%
Dec 31, 201941.33M3.36M8.84%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk A/S 270.58B
Coloplast A/S 27.03B
Genmab A/S 19.84B
Demant A/S 22.84B
H. Lundbeck A/S 21.44B
H. Lundbeck A/S 21.44B
ALK-Abelló A/S 5.38B
Ambu A/S 5.39B
Revenue Rankings

Zealand Pharma News

More News